HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$6.99
Day range
$6.85 - $7.07
Year range
$5.51 - $12.65
Market cap
2.14B USD
Avg Volume
4.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 154.69M | 22.12% |
Operating expense | 147.24M | 46.60% |
Net income | -24.42M | -55.57% |
Net profit margin | -15.79 | -27.44% |
Earnings per share | 0.01 | -83.33% |
EBITDA | -5.92M | -134.52% |
Effective tax rate | -27.31% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 231.00M | -11.18% |
Total assets | 815.30M | 8.78% |
Total liabilities | 611.00M | -0.97% |
Total equity | 204.30M | — |
Shares outstanding | 308.24M | — |
Price to book | 10.59 | — |
Return on assets | -2.42% | — |
Return on capital | -3.02% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -24.42M | -55.57% |
Cash from operations | -26.53M | -216.90% |
Cash from investing | -5.78M | 73.71% |
Cash from financing | -400.00K | 53.33% |
Net change in cash | -22.72M | -5,098.40% |
Free cash flow | -26.52M | -174.72% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
499
